These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36152044)

  • 1. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in glioma.
    Luo H; Ye M; Hu Y; Wu M; Cheng M; Zhu X; Huang K
    Aging (Albany NY); 2022 Sep; 14(19):7824-7850. PubMed ID: 36152044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Novel m6A Regulator-mediated Methylation Modification Patterns in Distinct Tumor Microenvironment Profiles to Identify and Predict Glioma Prognosis and Progression, T-cell Dysfunction, and Clinical Response to ICI Immunotherapy.
    Zhao B; Xiang Z; Wu B; Zhang X; Feng N; Wei Y; Zhang W
    Curr Pharm Des; 2023; 29(1):60-78. PubMed ID: 36503445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation regulator-mediated modification pattern defines tumor microenvironment immune infiltration landscape in colon cancer.
    Yuan S; Gao Y; Xia Y; Wang Z; Wang X
    Front Genet; 2022; 13():1008644. PubMed ID: 36276973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
    Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m5C regulator-mediated methylation modification phenotypes characterized by distinct tumor microenvironment immune heterogenicity in colorectal cancer.
    Chen Z; Li Q; Lin Y; Lin S; Gao J; Chen S
    Sci Rep; 2023 Jul; 13(1):11950. PubMed ID: 37488178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA methylation regulator-mediated modification patterns and tumor microenvironment characterization in gastric cancer.
    Meng Q; Lu YX; Ruan DY; Yu K; Chen YX; Xiao M; Wang Y; Liu ZX; Xu RH; Ju HQ; Qiu MZ
    Mol Ther Nucleic Acids; 2021 Jun; 24():695-710. PubMed ID: 33996253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
    Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
    Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.
    Du J; Ji H; Ma S; Jin J; Mi S; Hou K; Dong J; Wang F; Zhang C; Li Y; Hu S
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33594424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
    Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
    Front Immunol; 2021; 12():691811. PubMed ID: 34489938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma.
    Zhao J; Liu Z; Yang K; Shen S; Peng J
    Front Immunol; 2024; 15():1333923. PubMed ID: 38736884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Mitochondrial Ribosomal RNA Modification-Based Classification Contributes to Discriminate the Prognosis and Immunotherapy Response of Glioma Patients.
    Wang P; Li J; Wu M; Ye M; Huang K; Zhu X
    Front Immunol; 2021; 12():722479. PubMed ID: 34566979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subtypes, prognostic and immunotherapeutic relevant gene signatures mediated by DNA methylation regulators in hepatocellular carcinoma.
    Shi R; Zhao H; Zhao S; Yuan H
    Aging (Albany NY); 2022 Jun; 14(12):5271-5291. PubMed ID: 35771147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m
    Chong W; Shang L; Liu J; Fang Z; Du F; Wu H; Liu Y; Wang Z; Chen Y; Jia S; Chen L; Li L; Chen H
    Theranostics; 2021; 11(5):2201-2217. PubMed ID: 33500720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Huang X; Qiu Z; Li L; Chen B; Huang P
    Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Methylation Regulator-Meditated Modification Patterns Define the Distinct Tumor Microenvironment in Lung Adenocarcinoma.
    Yuan D; Wei Z; Wang Y; Cheng F; Zeng Y; Yang L; Zhang S; Li J; Tang R
    Front Oncol; 2021; 11():734873. PubMed ID: 34552879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
    Yu L; Ji T; Liao W; Xu Y; Fang Y; Zhu Q; Nie J; Yang D
    Clin Epigenetics; 2023 Mar; 15(1):43. PubMed ID: 36932439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA5mC Regulator-Mediated Molecular Clusters and Tumor Microenvironment Signatures in Glioblastoma.
    Yu X; Che Y; Li W; Zhang P; Yu Y; Chen J; Gong T; Cao F
    Front Cell Dev Biol; 2022; 10():1055567. PubMed ID: 36425533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinoma.
    Xu W; Li H; Hameed Y; Abdel-Maksoud MA; Almutairi SM; Mubarak A; Aufy M; Alturaiki W; Alshalani AJ; Mahmoud AM; Li C
    Oncol Res; 2023; 31(5):819-831. PubMed ID: 37547754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation heterogeneity attributable to a complex tumor immune microenvironment prompts prognostic risk in glioma.
    Ma S; Pan X; Gan J; Guo X; He J; Hu H; Wang Y; Ning S; Zhi H
    Epigenetics; 2024 Dec; 19(1):2318506. PubMed ID: 38439715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tryptophan metabolic gene-related subtypes, development of prognostic models, and characterization of tumor microenvironment infiltration in gliomas.
    Liu Y; Xiang J; Liao Y; Peng G; Shen C
    Front Mol Neurosci; 2022; 15():1037835. PubMed ID: 36407768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.